Literature DB >> 2624471

Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity.

C E Taylor1, M S Webb, A D Milner, P D Milner, L A Morgan, R Scott, G M Stokes, A S Swarbrick, G L Toms.   

Abstract

Interferon alfa was measured by an immunoradiometric assay in the nasopharyngeal secretions of a group of infants admitted to hospital with respiratory syncytial virus infection. Virus replication in the upper respiratory tract was assessed by infectivity assay and by an enzyme linked immunoadsorbent assay for the viral fusion protein on the same nasopharyngeal secretions. All infants were examined daily while in hospital and allocated a score based upon a subjective assessment of the severity of their illness. There was no significant correlation between interferon, virus, or fusion (F) protein secretion and severity of illness or age of infant. It is concluded that poor interferon alfa secretion does not underly the susceptibility of infants to severe infections with this virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2624471      PMCID: PMC1792921          DOI: 10.1136/adc.64.12.1656

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  19 in total

1.  Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections.

Authors:  C B Hall; R G Douglas; R L Simons; J M Geiman
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

2.  Interferon and respiratory syncytial virus.

Authors:  P S Gardner; R McGuckin; A Beale; R Fernandes
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

3.  Deficient production of leucocyte interferon (interferon-alpha) in vitro and in vivo in children with recurrent respiratory tract infections.

Authors:  D Isaacs; J R Clarke; D A Tyrrell; A D Webster; H B Valman
Journal:  Lancet       Date:  1981-10-31       Impact factor: 79.321

4.  Bronchiolitis.

Authors:  R Henry; A D Milner; G M Stokes
Journal:  Am J Dis Child       Date:  1983-08

5.  Interferon response of lymphocytes and resistance to infections.

Authors:  L Juhlin; K Cantell
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

6.  Interferon in nasal secretions from infants with viral respiratory tract infections.

Authors:  K McIntosh
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

7.  Quantitative shedding patterns of respiratory syncytial virus in infants.

Authors:  C B Hall; R G Douglas; J M Geiman
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

8.  Respiratory syncytial virus infection in north-east England.

Authors:  D G Sims; M A Downham; J McQuillin; P S Gardner
Journal:  Br Med J       Date:  1976-11-06

9.  Effect of anti-interferon serum of influenza virus infection in mice.

Authors:  A Hoshino; H Takenaka; O Mizukoshi; J Imanishi; T Kishida; M G Tovey
Journal:  Antiviral Res       Date:  1983-03       Impact factor: 5.970

10.  Respiratory syncytial virus infections in infants: quantitation and duration of shedding.

Authors:  C B Hall; R G Douglas; J M Geiman
Journal:  J Pediatr       Date:  1976-07       Impact factor: 4.406

View more
  11 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Problems and prospects of developing effective therapy for common cold viruses.

Authors:  S L Johnston
Journal:  Trends Microbiol       Date:  1997-02       Impact factor: 17.079

3.  Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a.

Authors:  R Y Sung; J Yin; S J Oppenheimer; J S Tam; J Lau
Journal:  Arch Dis Child       Date:  1993-10       Impact factor: 3.791

4.  Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.

Authors:  Rémi Villenave; Lindsay Broadbent; Isobel Douglas; Jeremy D Lyons; Peter V Coyle; Michael N Teng; Ralph A Tripp; Liam G Heaney; Michael D Shields; Ultan F Power
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

Review 5.  Respiratory syncytial virus: virology, diagnosis, and vaccination.

Authors:  G L Toms
Journal:  Lung       Date:  1990       Impact factor: 2.584

6.  Depletion of TAX1BP1 Amplifies Innate Immune Responses during Respiratory Syncytial Virus Infection.

Authors:  Delphyne Descamps; Andressa Peres de Oliveira; Lorène Gonnin; Sarah Madrières; Jenna Fix; Carole Drajac; Quentin Marquant; Edwige Bouguyon; Vincent Pietralunga; Hidekatsu Iha; Armando Morais Ventura; Frédéric Tangy; Pierre-Olivier Vidalain; Jean-François Eléouët; Marie Galloux
Journal:  J Virol       Date:  2021-08-25       Impact factor: 5.103

7.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Induction of type I interferons and interferon-inducible Mx genes during respiratory syncytial virus infection and reinfection in cotton rats.

Authors:  Lioubov M Pletneva; Otto Haller; David D Porter; Gregory A Prince; Jorge C G Blanco
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

Review 9.  Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.

Authors:  Diego R Hijano; Luan D Vu; Lawrence M Kauvar; Ralph A Tripp; Fernando P Polack; Stephania A Cormier
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

Review 10.  Cromolyns: treatment for the common cold.

Authors:  S L Johnston
Journal:  Clin Exp Allergy       Date:  1996-09       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.